Understanding Creatine Kinase-MB (CK-MB)

Introduction

Creatine Kinase-MB (CK-MB) is a cardiac enzyme that plays a crucial role in diagnosing heart-related conditions, particularly myocardial infarction (heart attack). It is one of the three isoenzymes of creatine kinase (CK), which helps in energy production within muscle cells.

Why is CK-MB Important?

CK-MB is predominantly found in heart muscle cells. When there is damage to the heart muscle, such as in a heart attack, CK-MB levels rise in the blood. This makes it a valuable biomarker for diagnosing and assessing the severity of myocardial infarction.

Normal and Elevated CK-MB Levels

  • Normal range: CK-MB levels are typically very low in a healthy individual.
  • Elevated levels: An increase in CK-MB often indicates heart muscle damage. It usually rises within 3–6 hours after the onset of a heart attack, peaks at 12–24 hours, and returns to normal within 48–72 hours.

CK-MB vs. Troponin

While CK-MB is useful for detecting heart attacks, troponin levels are now considered the gold standard. Troponin stays elevated longer than CK-MB, making it more reliable for diagnosing heart damage.

Other Causes of Elevated CK-MB

Although CK-MB is mainly associated with heart damage, other conditions can also lead to higher levels:

  • Muscle diseases
  • Severe physical exertion
  • Trauma
  • Myocarditis (inflammation of the heart muscle)
  • Certain medications

Clinical Use

A CK-MB test, along with troponin tests and ECG, helps doctors confirm a heart attack. It is particularly useful for detecting reinfarction (a second heart attack occurring shortly after the first).

Conclusion

CK-MB is an essential biomarker for assessing heart muscle damage, particularly in acute myocardial infarction. However, it is often used in conjunction with troponin tests and ECG for a more accurate diagnosis.

Source recommendations

1. American Heart Association Guidelines for Biomarkers in Acute Coronary Syndromes

  1. https://pubmed.ncbi.nlm.nih.gov/26472997/
  2. https://www.ahajournals.org/doi/10.1161/cir.0000000000000134
  3. https://www.heart.org/en/-/media/Files/Affiliates/MWA/North-Dakota/North-Dakota-Stroke-Cardiac-Conference/Cardiac-Biomarker-History-Characterization-of-Troponin-Assays-Impact-on-Cardiac-Care-Sep-13-2023.pdf?sc_lang=en
  4. https://www.ahajournals.org/doi/10.1161/cir.0000000000000133
  5. https://www.uscjournal.com/articles/contemporary-risk-stratification-acute-coronary-syndrome

2. European Society of Cardiology Guidelines on Acute Coronary Syndromes

  1. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Acute-Coronary-Syndromes-ACS-Guidelines
  2. https://academic.oup.com/eurheartj/article/44/38/3720/7243210
  3. https://pubmed.ncbi.nlm.nih.gov/37622654/
  4. https://academic.oup.com/eurheartj/article/42/14/1289/5898842
  5. https://pubmed.ncbi.nlm.nih.gov/32860058/

Our advantages:

patient2376100
Best practices from USA, EU and Japan
Our answers to your questions are based on the clinical recommendations of countries with the most developed healthcare systems in the field of cardiology in the USA, the EU and Japan.
prescription18648039
Always up-to-date information
On a daily basis, we monitor for you all new scientific research publications in leading scientific journals on medical issues of interest to you.
We monitor all innovations and changes in the field of cardiac disease treatment on a daily basis.
fvfflf7q
Get second opinion
Here you can learn everything that even your doctor may not know about cardiology (if he does not speak English and he does not read 117 leading medical journals on cardiology every month).
1xr4duup
The most comprehensive and up-to-date collection of free cardiology materials
Our website contains the most comprehensive and up-to-date collection of free cardiology materials in your country.
Every 3-5 years, half of the scientific approaches to treatment in the field of cardiology are reviewed as a result of specialized scientific discoveries. With us, you don't have to wait these years to learn about the best ways to treat you and your loved ones.
arrow
Please register in order to receive information regarding possible complications and new approaches to treatment of cardiovascular diseases via email in our Newsletters.
arrow